EQUATOR THERAPEUTICS, INC.
First-in-class small molecule drug that selectively activates mitochondrial uncoupling proteins to increase resting metabolic rate and thermogenesis
- Sector
- Biotech
- Headquarters
- Berkeley, CA
- Total capital
- $3.5M
- Federal grants
- $3.5M
- 3 awards · 2021–2025
- Rank in peer group#250 of 514
- Private capital raised
- None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 0
- 5 pending
Capital timeline
Latest events
- Federal grantHealth and Human S · Phase II · New Generation of Mitochondrial Uncouplers for the Treatment of Metabolic DIsorders$1.6M
- Federal grantHealth and Human S · Phase II · New Generation of Mitochondrial Uncouplers for the Treatment of Metabolic DIsorders$1.6M
- Federal grantHealth and Human S · Phase I · New Generation of Mitochondrial Uncouplers for the Treatment of Metabolic DIsorders$341K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 514 peers
Line = medianBiotech · Molecule
- Federal grants#250 · top 49%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
No founders are linked to this company yet.
Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.
Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026
Claim this profile to add your teamWhat it has protected
USPTO · 0 granted of 5- PendingCompositions And Methods For Treating Metabolic DisordersUSPTOApplication PCTUS2025046180
- PendingCompositions And Methods For Treating Metabolic DisordersUSPTOApplication PCTUS2025019369
- PendingCompositions And Methods For Treating Metabolic DisordersUSPTOApplication 63694703
Show all 5 patent records
- Compositions And Methods For Treating Metabolic DisordersApplication PCTUS2025046180Pending
- Compositions And Methods For Treating Metabolic DisordersApplication PCTUS2025019369Pending
- Compositions And Methods For Treating Metabolic DisordersApplication 63694703Pending
- Compositions And Methods For Treating Metabolic DisordersApplication 63694708Pending
- Compositions And Methods For Treating Metabolic DisordersApplication 63563847Pending
Related companies, and why
- OCMS BIO LLCSimilar federal contract value in Biotech · null in contracts
- CACHE DNA, INC.Similar federal contract value in Biotech · null in contracts
- Split Rock Therapeutics, LLCSimilar federal contract value in Biotech · null in contracts
- EXONANORNA, LLCSimilar federal contract value in Biotech · null in contracts
- Gadusol Laboratories, Inc.Similar federal contract value in Biotech · null in contracts
- MARPAM PHARMA, LLCSimilar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .